🇺🇸 FDA
Patent

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

granted A61KA61K2039/57A61K39/00

Quick answer

US patent 9474793 (Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/57, A61K39/00, A61P, A61P31/12